Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Renal protection has been observed in models of acute kidney injury, with improved function markers and reduced tissue damage
Retrieved June 25, 2023
Human data show no significant increase in congenital anomalies with inadvertent early exposure, although evidence is limited and observational
Administration Methods Approved Use (EPP): Administered via a subcutaneous implant that releases the drug slowly over 60 days for sustained photoprotection
09 1SICHUAN JISHENG BIOPHARMACEUTICAL CO.,LTD 10 2Shenzhen Alvantis Pharma Co., Ltd
Rodrigue et al
US$ 21.70
US$ 25.01
US$ 20.76
US$ 28.37
US$ 24.84
US$ 22.25
US$ 29.08
.webp)
US$ 28.81
US$ 22.50
US$ 28.84
